Hospital Universitari Son Dureta
12
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.3%
1 terminated/withdrawn out of 12 trials
87.5%
+1.0% vs industry average
25%
3 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Efficacy of Simvastatin for the Treatment of COPD
Role: lead
Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients
Role: collaborator
Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study.
Role: lead
Effect of Gutamine Administration in the Innate Immune System Response in ICU Patients.
Role: lead
GROUP FOR TRALI STUDY. SEMICYUC.
Role: collaborator
Stress Hyperglycemia. Potential Role of Incretin Analogs
Role: lead
Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications
Role: lead
Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults
Role: lead
Endothelial Dysfunction in Chronic Obstructive Pulmonary Disease
Role: lead
Effects of Low-Dose Theophylline During Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Role: lead
Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial Hypertension
Role: lead
Pulmonary and Systemic Hepatocyte Growth Factors in Patients With COPD
Role: lead
All 12 trials loaded